Skip to content

Nalbuphine and Flurbiprofen for Oculoplastic Surgery

Flurbiprofen Axetil and Nalbuphine for Postoperative Pain and Discomfort After Oculoplastic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03422887
Enrollment
330
Registered
2018-02-06
Start date
2018-01-18
Completion date
2018-09-30
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery, Anesthesia, Pain

Keywords

postoperative pain, general anesthesia, postoperative discomfort

Brief summary

The purpose of this study is to evaluate the postoperative pain and discomfort using flurbiprofen axetil or nalbuphine administration after oculoplastic surgery under general anesthesia.

Detailed description

In this randomized controlled clinical trial, we evaluated the postoperative analgesic efficacy and adverse effects of flurbiprofen axetil combined with nalbuphine in patients undergoing oculoplastic surgery compared with a single dose of flurbiprofen axetil or nalbuphine.

Interventions

DRUGNalbuphine

Nalbuphine administration during surgery

Flurbiprofen axetil administration during surgery

Nalbuphine and Flurbiprofen Axetil administration during surgery

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Undergoing oculoplastic surgery * age between 16 and 75 years * American Society of Anesthesiologists (ASA) physical status of I-II

Exclusion criteria

* serious coexisting disease * body mass index (BMI) \<18.5 or \>35 * contraindications or previous adverse reactions to any of the drugs used * females with a positive pregnancy test * patients unable to cooperate

Design outcomes

Primary

MeasureTime frameDescription
Pain 24 hours after recovery24 hours after recoveryPain levels measured using Numerical Rating Scale (NRS) ranging from 0 to 10, where 0 represents no pain and 10 represents the worst pain imaginable ; this scale has been confirmed to be sensitive and reliable.Clinically significant postoperative pain was considered serious pain (NRS score ≥5).

Secondary

MeasureTime frameDescription
Discomfort 24 hours after recovery24 hour after recoveryDiscomfort levels were measured using Numerical Rating Scale (NRS) ranging from 0 to 10, where 0 represents no discomfort and 10 represents the worst discomfort; this scale has been confirmed to be sensitive and reliable. Discomfort was defined as sensation other than pain and included nausea, vomiting, headache, and dizziness. Clinically significant postoperative discomfort was considered serious discomfort (NRS score ≥5) any time postoperatively.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026